APA (7th ed.) Citation

Oberg, H., Deseke, M., Krohn, S., Winterberg, D., Peipp, M., Bauerschlag, D., . . . Baumann, C. (2025). Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: A novel strategy for safe and potent immunotherapy in ovarian cancer. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Oberg, Hans-Heinrich, Malte Deseke, Steffen Krohn, Dorothee Winterberg, Matthias Peipp, Dirk Bauerschlag, Klaus-Peter Künkele, Daniela Wesch, and Christoph Baumann. Tumor-restricted Activation of Vγ9Vδ2 T Cells via Bispecific Evobodies: A Novel Strategy for Safe and Potent Immunotherapy in Ovarian Cancer. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Oberg, Hans-Heinrich, et al. Tumor-restricted Activation of Vγ9Vδ2 T Cells via Bispecific Evobodies: A Novel Strategy for Safe and Potent Immunotherapy in Ovarian Cancer. Frontiers Media S.A, 2025.